BR112014012521A2 - novos derivados de pirrolidina como inibidores de catepsina - Google Patents

novos derivados de pirrolidina como inibidores de catepsina

Info

Publication number
BR112014012521A2
BR112014012521A2 BR112014012521A BR112014012521A BR112014012521A2 BR 112014012521 A2 BR112014012521 A2 BR 112014012521A2 BR 112014012521 A BR112014012521 A BR 112014012521A BR 112014012521 A BR112014012521 A BR 112014012521A BR 112014012521 A2 BR112014012521 A2 BR 112014012521A2
Authority
BR
Brazil
Prior art keywords
pyrrolidine derivatives
cathepsin inhibitors
new pyrrolidine
new
cathepsin
Prior art date
Application number
BR112014012521A
Other languages
English (en)
Inventor
Kuhn Bernd
Banner David
Peters Jens-Uwe
Schulz-Gasch Tanja
Luebbers Thomas
Haap Wolfgang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112014012521A2 publication Critical patent/BR112014012521A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

resumo novos derivados de pirrolidina como inibidores de catepsina a invenção se refere a um composto da fórmula (i) (i) nnhoor2r3so2r5r6r7r4ar1 em que a e r1 a r7 são definidos como no relatório descritivo e nas reivindicações. o composto da formula (i) pode ser utilizado como um medicamento.
BR112014012521A 2011-11-25 2012-11-20 novos derivados de pirrolidina como inibidores de catepsina BR112014012521A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11190756 2011-11-25
PCT/EP2012/073073 WO2013076063A1 (en) 2011-11-25 2012-11-20 Novel pyrrolidine derivatives as inhibitors of cathepsin

Publications (1)

Publication Number Publication Date
BR112014012521A2 true BR112014012521A2 (pt) 2017-06-06

Family

ID=47216270

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014012521A BR112014012521A2 (pt) 2011-11-25 2012-11-20 novos derivados de pirrolidina como inibidores de catepsina

Country Status (11)

Country Link
US (1) US8729061B2 (pt)
EP (1) EP2782903B1 (pt)
JP (1) JP2014533707A (pt)
KR (1) KR20140102253A (pt)
CN (1) CN103946213A (pt)
AR (1) AR088969A1 (pt)
BR (1) BR112014012521A2 (pt)
CA (1) CA2854569A1 (pt)
MX (1) MX2014006211A (pt)
RU (1) RU2014123784A (pt)
WO (1) WO2013076063A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6654636B2 (ja) 2014-12-02 2020-02-26 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 新規ピペリジン誘導体
CR20180404A (es) * 2016-02-26 2018-10-18 Hoffmann La Roche Nuevos derivados pirrolidina
US10590084B2 (en) 2016-03-09 2020-03-17 Blade Therapeutics, Inc. Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
US11292801B2 (en) 2016-07-05 2022-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
MX2019003425A (es) 2016-09-28 2019-08-16 Blade Therapeutics Inc Moduladores de calpainas y usos terapeuticos de los mismos.
WO2023130334A1 (zh) * 2022-01-07 2023-07-13 同润生物医药(上海)有限公司 一种色烯-4-酮化合物及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007013387D1 (de) * 2006-05-23 2011-05-05 Irm Llc Verbindungen und zusammensetzungen als kanalaktivierende protease-hemmer
WO2007137080A2 (en) * 2006-05-23 2007-11-29 Irm Llc Compounds and compositions as channel activating protease inhibitors
MX2009008518A (es) * 2007-02-09 2009-08-20 Irm Llc Compuestos y composiciones como inhibidores de la proteasa activadora de canal.
AU2008214214B2 (en) * 2007-02-09 2011-09-15 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2009100225A1 (en) 2008-02-07 2009-08-13 Virobay, Inc. Inhibitors of cathepsin b
KR101320790B1 (ko) 2009-04-20 2013-10-22 에프. 호프만-라 로슈 아게 카텝신 억제제로서의 프롤린 유도체

Also Published As

Publication number Publication date
US20130137687A1 (en) 2013-05-30
AR088969A1 (es) 2014-07-23
EP2782903A1 (en) 2014-10-01
KR20140102253A (ko) 2014-08-21
CN103946213A (zh) 2014-07-23
JP2014533707A (ja) 2014-12-15
EP2782903B1 (en) 2016-04-06
WO2013076063A1 (en) 2013-05-30
CA2854569A1 (en) 2013-05-30
US8729061B2 (en) 2014-05-20
MX2014006211A (es) 2014-08-08
RU2014123784A (ru) 2015-12-27

Similar Documents

Publication Publication Date Title
BRPI1013567B8 (pt) Derivados de prolina como inibidores de catepsina
BR112015012919A2 (pt) novos derivados de piridina
ECSP13013074A (es) Nuevos derivados de piridina
CR20150045A (es) Inhibidores de hepatitis c
CO6620065A2 (es) Compuestos heteroarilo nitrogenados
BR112015013124A2 (pt) novos derivados de piridina
UA111161C2 (uk) Похідна фталазинонкетону, спосіб її одержання та її фармацевтичне застосування
EA201490724A1 (ru) Замещенные соединения тетрагидроизохинолина в качестве ингибиторов фактора xia
BR112015020795A2 (pt) derivados de pirazol novos
ECSP12012103A (es) Inhibidores de virus flaviviridae.
BR112015009600A2 (pt) piridina-2-amidas úteis como agonistas cb2
BR112014010047A2 (pt) novos derivados de pirazina
BR112015009603A2 (pt) novos derivados de pirazina
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
BR112014012521A2 (pt) novos derivados de pirrolidina como inibidores de catepsina
CO6741154A2 (es) Compuestos de triazolopiridina
CO7350640A2 (es) Compuestos diméricos
BR112014006248A2 (pt) compostos de triazolopiridina como inibidores de pde10a
CR20150440A (es) Nuevos derivados de piridina
BR112014016803A2 (pt) amidas macrocíclicas como inibidoras de protease
BR112018011562A2 (pt) novos derivados de fenil
BR112014028006A2 (pt) heterociclos de pirrolidino
CR20150041A (es) Azaheterociclos como inhibidores de bir2 y/o bir3
BR112014019220A8 (pt) Novos derivados de pirrolidina
MX342960B (es) Derivados de cromeno.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]